Digital Sponsored Clinical trials at the core: Decentralised, AI targeted, ESG... For Inventus' Steve Sanghera and Jim Michel 2025 was a year of progress in clinical trial enablement.
Oncology Hernexeos and what’s next, with Vicky Brown At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.